Abstract
Epidemiological studies on the association between the single nucleotide polymorphism (SNP) at −420 C/G (rs1862513) in the human resistin gene (RETN) and the risk of type 2 diabetes mellitus (T2DM) are conflicting. In order to derive a more precise estimation of the association, a meta-analysis was conducted. Twelve studies with 5,935 cases and 5,959 controls were enrolled by searching the databases of Medline, EMBASE, and Cochrane. Summary odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. The heterogeneity and publication bias were investigated. The main analysis indicated no significant association [for allelic model: OR = 0.97 (0.92–1.03); for additive model: OR = 0.95 (0.83–1.09); for recessive model: OR = 0.98 (0.86–1.12); for dominant model: OR = 0.95 (0.88–1.04)]. Overall, no significant heterogeneity was found. Subgroup analysis by race and source of controls indicated no significant association. In conclusion, the current meta-analysis did not observe any association between the polymorphism of RETN −420 C/G and the risk of T2DM. The study may help us further understand the genetics of T2DM. However, larger and prospective studies are warranted to confirm this finding.
Abbreviations
- BNP:
-
Brain natriuretic peptide
- CI:
-
Confidence interval
- OR:
-
Odds ratio
- RETN:
-
Resistin gene
- T2DM:
-
Type 2 diabetes mellitus
References
Zimmet P (2000) Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted? J Intern Med 247(3):301–310
Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414(6865):782–787
De Fronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM a balanced overview. Diabetes Care 15(3):318–368
Choquet H, Cavalcanti-Proenca C, Lecoeur C et al (2009) The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects. Hum Mol Genet 18(13):2495–2501
Gouda HN, Sagoo GS, Harding AH et al (2010) The association between the peroxisome proliferator receptor-γ2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am J Epidemiol 171(6):645–655
McGarthy MI, Zeggini E (2009) Genome-wide association studies in type 2 diabetes. Curr Diab Rep 9(2):164–171
Voight BF, Scott LJ, Steinthorsdottir V et al (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42(7):579–589
Holcomb IN, Kabakoff RC, Chan B et al (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19(15):4046–4055
McTernan PG, Kusminski CM, Kumar S (2006) Resistin. Curr Opin Lipidol 17(2):170–175
Steppan CM, Bailey ST, Bhat S et al (2001) The hormone resistin links obesity to diabetes. Nature 409(6818):307–312
Norata GD, Ongari M, Garlaschelli K et al (2007) Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol 156(2):279–284
Osawa H, Tabara Y, Kawamoto R et al (2007) Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Diabetes Care 30(6):1501–1506
Hivert MF, Sullivan LM, Fox CS et al (2008) Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab 93(8):3165–3172
Menzaghi C, Coco A, Salvemini L et al (2006) Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians. J Clin Endocrinol Metab 91(7):2792–2795
Hivert MF, Manning AK, McAteer JB et al (2009) Association of variants in RETN with plasma resistin levels and diabetes-related traits in the framingham offspring study. Diabetes 58(3):750–756
Osawa H, Yamada K, Onuma H et al (2004) The G/G genotype of a resistin single-nucleotide polymorphism at −420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet 75(4):678–686
Emamgholipour S, Hossein-nezhad A, Najmafshar A et al (2009) Promoter resistin gene polymorphism in patients with type 2 diabetes and its influence on concerned metabolic phenotypes. Iran J Diabetes Lipid Disord 8:150–156
Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820–823
Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560
Eggert M, Davey SG, Schneider M et al. (91997) Bias in meta-analysis detected by a simple graphical test. BMJ 315(7109):629–634
Engert JC, Vohl MC, Williams SM et al (2002) 5′ flanking variants of resistin are associated with obesity. Diabetes 51(5):1629–1634
Ma X, Warram JH, Trischitta V et al (2002) Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians. J Clin Endocrinol Metab 87(9):4407–4410
Cho YM, Youn BS, Chung SS et al (2004) Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 47(3):559–565
Cho YM, Ritchie MD, Moore JH et al (2004) Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus. Diabetologia 47(3):549–554
Bouchard L, Weisnagel SJ, Engert JC et al (2004) Human resistin gene polymorphism is associated with visceral obesity and fasting and oral glucose stimulated C-peptide in the Quebec Family Study. J Endocrinol Invest 27(11):1003–1009
Conneely KN, Silander K, Scott LJ et al (2004) Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia 47(10):1782–1788
Osawa H, Onuma H, Ochi M et al (2005) Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. Biochem Biophys Res Commun 335(2):596–602
Kunnari A, Ukkola O, Kesäniemi YA (2005) Resistin polymorphisms are associated with cerebrovascular disease in finnish type 2 diabetic patients. Diabet Med 22(5):583–589
Ochi M, Osawa H, Hirota Y et al (2007) Frequency of the G/G genotype of resistin single nucleotide polymorphism at −420 appears to be increased in younger-onset type 2 diabetes. Diabetes 56(11):2834–2838
Suriyaprom K, Phonrat B, Namjuntra P et al (2009) The +299(G > A) resistin gene polymorphism and susceptibility to type 2 diabetes in Thais. J Clin Biochem Nutr 44(1):104–110
Tsukahara T, Nakashima E, Watarai A et al (2009) Polymorphism in resistin promoter region at −420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients. Diabetes Res Clin Pract 84(2):179–186
Chi S, Lan C, Zhang S et al (2009) Association of −394C > G and −420C > G polymorphisms in the RETN gene with T2DM and CHD and a new potential SNP might be exist in exon 3 of RETN gene in Chinese. Mol Cell Biochem 330(1–2):31–38
Acknowledgments
This work was supported by the National Science Foundation of China (No. 30771805).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wen, Y., Lu, P. & Dai, L. Association between resistin gene −420 C/G polymorphism and the risk of type 2 diabetes mellitus: a meta-analysis. Acta Diabetol 50, 267–272 (2013). https://doi.org/10.1007/s00592-010-0247-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-010-0247-8